Nova Eye Medical

Aging Populations And MIGS Advances Will Expand Ophthalmic Markets

AnalystHighTarget

Not Invested

Consensus Narrative from 3 Analysts

Published

01 Sep 25

AnalystHighTarget's Fair Value

AU$0.50

67.0% undervalued

11 Sep

AU$0.17

-2.9%

15.8%

-2.9%

15.8%

You can edit this narrative until Sep 1 9:22 PM. Then, changes will post as Updates.

Author's Valuation

AU$0.5

67.0% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

AU$0.5

67.0% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

21.95%

Medical Equipment revenue growth rate

0.40%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.14%

Calculation

AU$15.92m

Earnings '28

21.00x

PE Ratio '28

AU$334.40m

Market Cap '28

AU$334.40m

Market Cap '28

543.35m

No. shares '28

AU$0.62

Share Price '28

AU$0.62 Share Price '28

Discounted to 2025 @ 7.17% p.a.

AU$0.50

Fair Value '25